Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Archit Organosys's 3-Year RORE % for the quarter that ended in Mar. 2026 was 32.48%.
The industry rank for Archit Organosys's 3-Year RORE % or its related term are showing as below:
BOM:524640's 3-Year RORE % is ranked better than 71.51% of 1520
companies
in the Chemicals industry
Industry Median: 7.23
vs BOM:524640: 32.48
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Archit Organosys 3-Year RORE % Related Terms
Archit Organosys 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Archit Organosys's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Archit Organosys's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Archit Organosys 3-Year RORE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Archit Organosys's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Archit Organosys's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Archit Organosys (BOM:524640) has a 3-Year RORE % of 32.48 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Archit Organosys and its competitors. According to the industry distribution chart, Archit Organosys ranks #433 out of 1520 companies in the Chemicals industry, placing it in the top 28.5%.
Is Archit Organosys' 3-Year RORE % too high?
Archit Organosys' current 3-Year RORE % is 32.48. The Chemicals industry median 3-Year RORE % is 7.23. Archit Organosys' value of 32.48 is 349.2% above this industry median. Based on the distribution chart, Archit Organosys ranks #433 out of 1520 companies in the Chemicals industry, which is above the industry midpoint. Overall, Archit Organosys has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Archit Organosys' 3-Year RORE % compare to DOW?
According to the Chemicals industry distribution chart, Archit Organosys ranks #433 out of 1520 companies for 3-Year RORE %. This puts Archit Organosys in the upper half of its industry. The industry median 3-Year RORE % is 7.23. Archit Organosys' value of 32.48 is 349.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Chemicals company?
The median 3-Year RORE % among Chemicals companies is 7.23, based on 1,520 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Archit Organosys's current 3-Year RORE % of 32.48 is 349.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Archit Organosys and its competitors. For the Chemicals industry, the median 3-Year RORE % is 7.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Archit Organosys's current 3-Year RORE % is 32.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Archit Organosys stock overvalued right now?
Based on GuruFocus' analysis, Archit Organosys (BOM:524640) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹55.46, compared to a current price of ₹63.58 — trading 14.6% above its estimated fair value. The current 3-Year RORE % is 32.48 and 349.2% above the Chemicals industry median of 7.23. Archit Organosys' overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Archit Organosys (BOM:524640), the current 3-Year RORE % is 32.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Archit Organosys (BOM:524640) Overvalued in 2026?
Based on GuruFocus' analysis, Archit Organosys stock appears to be overvalued.
The current stock price of ₹63.58 is trading 14.6% above its estimated GF Value™ of ₹55.46.
GuruFocus considers Archit Organosys to be Modestly Overvalued.
Key valuation signals for BOM:524640:
3-Year RORE %: 32.48
GF Value™: ₹55.46 vs. price of ₹63.58 (14.6% above fair value)
Industry Position: 349.2% above the Chemicals median (#433 of 1520)
No single metric tells the full story. See the BOM:524640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Archit Organosys Ltd is mainly engaged in the manufacturing and selling of various chemical products, including alkali chemicals, inorganic chemicals, organic chemicals, pesticides and insecticides, dyes, and dyestuff. The company mainly manufactures and trades chemicals such as Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloroacetyl Chloride, and Trichloroacetyl Chloride (TCAC). It operates in a single segment identified as manufacturing and trading of dyes, chemicals, and pigments. Geographically, it derives the majority of its revenue from India and also exports products to other countries.
64GF Score
Get the complete analysis for BOM:524640
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524640 has been successfully added to your 
